184 related articles for article (PubMed ID: 31523825)
1. MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List.
Asrani SK; Jennings LW; Kim WR; Kamath PS; Levitsky J; Nadim MK; Testa G; Leise MD; Trotter JF; Klintmalm G
Hepatology; 2020 May; 71(5):1766-1774. PubMed ID: 31523825
[TBL] [Abstract][Full Text] [Related]
2. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
3. MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level.
Chetwood JD; Wells MG; Tsoutsman T; Pulitano C; Crawford MD; Liu K; Strasser SI; McCaughan GW; Majumdar A
Transplant Direct; 2022 Jul; 8(7):e1346. PubMed ID: 35706607
[TBL] [Abstract][Full Text] [Related]
4. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
[TBL] [Abstract][Full Text] [Related]
6. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
7. Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate.
Myers RP; Shaheen AA; Aspinall AI; Quinn RR; Burak KW
J Hepatol; 2011 Mar; 54(3):462-70. PubMed ID: 21109324
[TBL] [Abstract][Full Text] [Related]
8. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
[TBL] [Abstract][Full Text] [Related]
9. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
[TBL] [Abstract][Full Text] [Related]
10. Hyponatremia and mortality among patients on the liver-transplant waiting list.
Kim WR; Biggins SW; Kremers WK; Wiesner RH; Kamath PS; Benson JT; Edwards E; Therneau TM
N Engl J Med; 2008 Sep; 359(10):1018-26. PubMed ID: 18768945
[TBL] [Abstract][Full Text] [Related]
11. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
[TBL] [Abstract][Full Text] [Related]
12. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region.
Goudsmit BFJ; Putter H; Tushuizen ME; de Boer J; Vogelaar S; Alwayn IPJ; van Hoek B; Braat AE
Am J Transplant; 2021 Jan; 21(1):229-240. PubMed ID: 32529758
[TBL] [Abstract][Full Text] [Related]
14. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
[TBL] [Abstract][Full Text] [Related]
16. Impact of creatinine values on MELD scores in male and female candidates for liver transplantation.
Mariante-Neto G; Marroni CP; Fleck Junior AM; Marroni CA; Zanotelli ML; Cantisani G; Brandão AB
Ann Hepatol; 2013; 12(3):434-9. PubMed ID: 23619260
[TBL] [Abstract][Full Text] [Related]
17. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
[TBL] [Abstract][Full Text] [Related]
18. MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis.
Kim JW; Kim JH; Choe WH; Kwon SY; Yoo BC
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984593
[No Abstract] [Full Text] [Related]
19. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.
Francoz C; Prié D; Abdelrazek W; Moreau R; Mandot A; Belghiti J; Valla D; Durand F
Liver Transpl; 2010 Oct; 16(10):1169-77. PubMed ID: 20879015
[TBL] [Abstract][Full Text] [Related]
20. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
